Stealth’s injection, known as elamipretide, will be sold as Forzinity for the treatment of Barth syndrome, an X-linked ...
While the test was conducted in NSCLC, the FDA approval includes existing solid tumor indications for Keytruda. Merck is ...
The Centers for Disease Control and Prevention (CDC) has come out with a strong recommendation for the use of Gilead Sciences ...
Eli Lilly has been censured by the U.K. marketing watchdog after a complainant reported being hit by a “bombardment of spam.” ...
BMS is exiting the first U.S.-China pharmaceutical joint venture. Kalexo Bio and Ollin Biosciences have launched with big ...
After swiftly developing its COVID-19 vaccine in 2020 and launching it late that year, Moderna soon found itself facing ...
In a perplexing conclusion to an oftentimes tense meeting of the CDC’s Advisory Committee on Immunization Practices (ACIP) ...
Separately, the ACIP members reversed their vote on a recommendation they’d shot down Thursday pertaining to coverage of ...
The duel of the GLP-1 data sets continues this week, with Novo issuing the latest salvo of updates on its oral obesity ...
Over the last six years, three GLP-1 drugs have been approved for children aged 10 and older with Type 2 diabetes. | Over the ...
SK Biopharmaceutical’s Xcopri (cenobamate) met the bar in a phase 3 trial that could support the company’s ambitions of ...
Nearly three years after originating the role, Erica Taylor, Ph.D., is stepping down as chief marketing officer of Genentech.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback